References
- 1. Hartley JL, Davenport M, Kelly DA. Biliary atresia.
- Lancet. 2009; 374:1704-13.19189430
- 2. Bassett MD, Murray KF. Biliary atresia: recent progress. J Clin Gastroenterol. 2008; 42:720-9.10.1097/MCG.0b013e3181646730
- 3. Erlichman J, Hohlweg K, Haber BA. Biliary atresia: how medical complications and therapies impact outcome. Expert Rev Gastroenterol Hepatol. 2009; 3: 425-34.10.1586/egh.09.30
- 4. A-Kader HH, Abdel-Hameed A, Al-Shabrawi M, Mohsen N, El-Karaksy H, Hassanein B, et al. Is biliary atresia an autoimmune disease? Eur J Gastroenterol Hepatol. 2003; 15:447.10.1097/00042737-200304000-00020
- 5. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996; 271:10697-703.
- 6. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.
- Trends Endocrinol Metab. 2002; 13:84-9.11854024
- 7. Shimizu A, Takamura T, Matsuzawa N, Nakamura S, Nabemoto S, Takeshita Y, et al. Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line. Metabolism. 2007; 56:1478-85.10.1016/j.metabol.2007.06.013
- 8. Bertolani C, Marra F. Role of adipocytokines in hepatic fibrosis. Curr Pharm Des. 2010; 16:1929-40.10.2174/138161210791208857
- 9. Marra F, Bertolani C. Adipokines in liver diseases.
- Hepatology. 2009; 50:957-69.19585655
- 10. Honsawek S, Chongsrisawat V, Praianantathavorn K, Theamboonlers A, Poovorawan Y. Elevation of Serum Galectin-3 and Liver Stiffness Measured by Transient Elastography in Biliary Atresia. Eur J Pediatr Surg. 2011; 21:250-4.10.1055/s-0031-1273776
- 11. Honsawek S, Praianantathavorn K, Chongsrisawat V, Vejchapipat P, Theamboonlers A, Poovorawan Y.
- High serum matrix metalloproteinase-3 and liver stiffness in postoperative biliary atresia. Pediatr Surg Int. 2011; 27:681-7.21191599
- 12. Honsawek S, Chayanupatkul M, Chongsrisawat V, Vejchapipat P, Poovorawan Y. Increased osteopontin and liver stiffness measurement by transient elastography in biliary atresia. World J Gastroenterol. 2010; 16:5467-73.10.3748/wjg.v16.i43.5467
- 13. Chayanupatkul M, Honsawek S, Vejchapipat P, Chongsrisawat V, Poovorawan Y. Elevated serum bone morphogenetic protein 7 levels and clinical outcome in children with biliary atresia. Eur J Pediatr Surg. 2009; 19:246-50.10.1055/s-0029-1216378
- 14. Honsawek S, Chayanupatkul M, Chongsrisawat V, Theamboonlers A, Praianantathavorn K, Udomsinprasert W, et al. Serum adiponectin and transient elastography as non-invasive markers for postoperative biliary atresia. BMC Gastroenterol. 2011; 11:16.10.1186/1471-230X-11-16
- 15. Liu CJ, Chen PJ, Lai MY, Liu CH, Chen CL, Kao JH, et al. High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection. Hepatol Int. 2009; 3:364-70.10.1007/s12072-008-9111-0
- 16. Arano T, Nakagawa H, Tateishi R, Ikeda H, Uchino K, Enooku K, et al. Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. Int J Cancer. 2010;129:2226-35.10.1002/ijc.25861
- 17. Baranova A, Jarrar MH, Stepanova M, Johnson A, Rafiq N, Gramlich T, et al. Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C. Digestion. 2011; 83: 32-40.
- 18. Latif HA, Assal HS, Mahmoud M, Rasheed WI. Role of serum adiponectin level in the development of liver cirrhosis in patients with hepatitis C virus. Clin Exp Med. 2011; 11:123-9.10.1007/s10238-010-0108-3
- 19. Ma H, Gomez V, Lu L, Yang X, Wu X, Xiao SY.
- Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2009; 24:233-7 18713296